Watchlist Price Alert

Hikma Pharmaceuticals (HKMPF)

PNK: HKMPF · Real-Time Price · USD

26.20

-0.36 (-1.36%)

At close: May 01, 2025, 8:00 PM

Hikma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	1.56B	1.57B	1.45B	1.43B	1.3B	1.21B	1.34B	1.22B	1.21B	1.13B	1.16B	1.05B	1.09B	979M	1.04B	895M	1.07B	882M
Cost of Revenue	899M	813M	756M	712M	662M	590M	652M	600M	573M	555M	585M	523M	555M	511M	553M	468M	567M	433M
Gross Profit	659M	756M	692M	715M	642M	623M	685M	616M	636M	577M	575M	524M	536M	468M	488M	427M	501M	449M
Operating Income	261M	351M	310M	309M	202M	296M	252M	309M	258M	282M	230M	256M	213M	215M	184M	152M	243M	158M
Interest Income	n/a	40M	25M	41M	24M	32M	18M	24M	15M	19M	8M	22M	14M	24M	21M	28M	17M	29M
Pretax Income	167M	288M	79M	202M	18M	215M	225M	319M	284M	274M	265M	226M	152M	141M	-838M	100M	127M	83M
Net Income	133M	226M	59M	131M	15M	173M	173M	248M	219M	212M	301M	185M	176M	106M	-912M	69M	97M	58M
Selling & General & Admin	382M	280M	371M	261M	345M	256M	329M	232M	277M	229M	271M	216M	259M	208M	252M	222M	228M	201M
Research & Development	77.54M	61M	85M	64M	75M	69M	84M	59M	75M	62M	78M	72M	84M	63M	58M	63M	93M	57M
Other Expenses	-61.54M	64M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	398M	405M	588M	472M	600M	376M	442M	273M	337M	284M	302M	276M	370M	303M	1.3B	299M	357M	337M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	120M	116M	115M	106M
Cost & Expenses	1.3B	1.22B	1.34B	1.18B	1.26B	966M	1.09B	873M	910M	839M	887M	799M	925M	814M	1.86B	767M	924M	770M
Income Tax Expense	34M	59M	18M	71M	1M	41M	53M	71M	66M	62M	37M	41M	24M	32M	71M	30M	28M	24M
Shares Outstanding (Basic)	221.85M	223.76M	226.45M	222.03M	220.46M	227.93M	233.97M	231.99M	232.87M	243.12M	242.9M	242.15M	241.99M	242.01M	240M	241M	240M	228M
Shares Outstanding (Diluted)	223.04M	223.76M	222.74M	222.03M	221.82M	228M	234M	232M	233M	243M	242.9M	243.1M	241.99M	242.01M	240M	241M	240M	228M
EPS (Basic)	0.60	1.01	0.26	0.59	0.07	0.76	0.74	1.07	0.94	0.87	1.24	0.76	0.73	0.44	-3.8	0.29	0.40	0.25
EPS (Diluted)	0.60	1.01	0.26	0.59	0.07	0.76	0.74	1.07	0.94	0.87	1.24	0.76	0.73	0.44	-3.8	0.29	0.40	0.25
EBITDA	288M	499M	345M	446M	284M	386M	382M	336M	317M	337M	279M	305M	261M	266M	248M	213M	295M	211M
EBIT	206M	402M	310M	309M	202M	296M	252M	309M	258M	282M	230M	256M	213M	215M	184M	152M	243M	158M
Depreciation & Amortization	82M	97M	35M	137M	82M	90M	130M	27M	59M	55M	49M	49M	48M	51M	64M	61M	52M	53M